Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
232
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

446
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
446
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

779
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
779
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

712
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
712
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.3K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.3K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychosocial functional recovery in patients with bipolar disorder in remission: Which symptoms hold them back?

Journal of affective disorders·2026
Same author

Milia-Like Papules and Ulcerated Nodules in a Man With Bartter Syndrome.

Actas dermo-sifiliograficas·2025
Same author

Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology.

Actas dermo-sifiliograficas·2025
Same author

[Translated article] Methotrexate-Induced Gouty Arthritis in Psoriatic Patient.

Actas dermo-sifiliograficas·2025
Same author

Methotrexate-Induced Gouty Arthritis in Psoriatic Patient.

Actas dermo-sifiliograficas·2025
Same author

[Translated article] Updated Perspective from the Spanish Psoriasis Working Group (GPS) on Biosimilar Drug Use in Moderate-to-Severe Psoriasis.

Actas dermo-sifiliograficas·2025
Same journal

Fingolimod-associated lymphomatoid papulosis.

Actas dermo-sifiliograficas·2026
Same journal

Demodicosis: update and treatment with laser and other light sources.

Actas dermo-sifiliograficas·2026
Same journal

New treatments for adult female acne.

Actas dermo-sifiliograficas·2026
Same journal

First regulations of the Spanish Society of Dermatology (1909).

Actas dermo-sifiliograficas·2026
Same journal

Long-hair FUE: advantages and disadvantages of the most recent technique in hair transplantation.

Actas dermo-sifiliograficas·2026
Same journal

Sunburns, Tanning, and Social Media: A Descriptive Study Among Spanish University Students.

Actas dermo-sifiliograficas·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.4K

Psychotropic Drugs: A Practical Guide for Use in Dermatology.

E Carmona-Rocha1, J De Diego-Adeliño2, M J Tribó3

  • 1Servicio de Dermatología y Venereología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Institut de Recerca Sant Pau (IR Sant Pau), Spain; Universitat Autònoma de Barcelona (UAB), Spain.

Actas Dermo-Sifiliograficas
|December 6, 2025
PubMed
Summary
This summary is machine-generated.

This review guides dermatologists on using psychotropic medications for patients with both skin and mental health conditions. It provides practical recommendations for managing psychiatric comorbidities in dermatology practice.

Keywords:
AnticonvulsantsAntidepressantsAntipsychoticsAnxiolyticsPsychodermatologyPsychodermatosesPsychotropic drugs

More Related Videos

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

3.2K
Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

42.7K

Related Experiment Videos

Last Updated: Jan 9, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.4K
Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

3.2K
Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

42.7K

Area of Science:

  • Psychodermatology
  • Clinical Dermatology
  • Psychopharmacology

Background:

  • High prevalence of psychiatric morbidity in dermatology patients.
  • Psychiatric disorders can manifest with skin symptoms.
  • Dermatological conditions significantly impact mental health.

Purpose of the Study:

  • To provide a practical guide on psychotropic drug use in dermatology.
  • To address the intersection of mental health and dermatology.
  • To equip dermatologists with tools for holistic patient management.

Main Methods:

  • Narrative review of psychotropic drug applications.
  • Focus on commonly used psychotropic medications.
  • Synthesis of information on indications, dosing, and adverse effects.

Main Results:

  • Comprehensive overview of psychotropic drug indications in dermatology.
  • Detailed information on dosing and adverse effects.
  • Considerations for special populations and contraindications.

Conclusions:

  • Psychotropic medications are essential for managing patients with psychodermatological conditions.
  • Dermatologists need guidance on psychotropic drug selection and management.
  • Integrated care improves therapeutic outcomes for patients at the intersection of dermatology and mental health.